ValuEngine downgraded shares of Tenet Healthcare (NYSE:THC) from a hold rating to a sell rating in a research note published on Friday morning.
Several other brokerages have also weighed in on THC. Citigroup increased their price objective on shares of Tenet Healthcare from $37.00 to $44.00 and gave the stock a buy rating in a report on Monday, July 23rd. Jefferies Financial Group lowered shares of Tenet Healthcare from a buy rating to a hold rating and increased their price objective for the stock from $28.00 to $38.00 in a report on Friday, June 29th. Zacks Investment Research upgraded shares of Tenet Healthcare from a hold rating to a buy rating and set a $36.00 price objective on the stock in a report on Tuesday, August 14th. Barclays assumed coverage on shares of Tenet Healthcare in a report on Tuesday, August 14th. They set an equal weight rating and a $35.00 price objective on the stock. Finally, JPMorgan Chase & Co. increased their price objective on shares of Tenet Healthcare from $22.00 to $28.00 and gave the stock an underweight rating in a report on Friday, August 10th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the stock. The company presently has an average rating of Hold and an average price target of $30.80.
Shares of THC stock traded down $0.04 during trading hours on Friday, hitting $25.39. 1,156,329 shares of the company were exchanged, compared to its average volume of 1,912,491. The firm has a market cap of $2.91 billion, a P/E ratio of 31.35, a PEG ratio of 1.27 and a beta of 0.92. Tenet Healthcare has a 1 year low of $12.25 and a 1 year high of $39.74. The company has a debt-to-equity ratio of 24.66, a current ratio of 1.08 and a quick ratio of 1.01.
A number of hedge funds and other institutional investors have recently bought and sold shares of THC. Wells Fargo & Company MN raised its holdings in Tenet Healthcare by 163.4% in the first quarter. Wells Fargo & Company MN now owns 186,667 shares of the company’s stock valued at $4,527,000 after buying an additional 481,111 shares during the period. Koch Industries Inc. purchased a new stake in shares of Tenet Healthcare during the first quarter valued at approximately $343,000. Principal Financial Group Inc. raised its stake in shares of Tenet Healthcare by 5.6% during the first quarter. Principal Financial Group Inc. now owns 368,795 shares of the company’s stock valued at $8,943,000 after purchasing an additional 19,705 shares during the period. Commonwealth Equity Services LLC purchased a new stake in shares of Tenet Healthcare during the first quarter valued at approximately $208,000. Finally, Allianz Asset Management GmbH raised its stake in shares of Tenet Healthcare by 2.7% during the first quarter. Allianz Asset Management GmbH now owns 150,325 shares of the company’s stock valued at $3,645,000 after purchasing an additional 3,950 shares during the period.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Further Reading: Average Daily Trade Volume Explained
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.